Estimates Revisions Joinn Laboratories(China)Co.,Ltd. Hong Kong S.E.
Stocks
6127
CNE100004BP3
Biotechnology & Medical Research
|
Market Closed -
Hong Kong S.E.
12:08:55 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 21.20 HKD | -2.93% |
|
-6.77% | +2.91% |
| 08-28 | Joinn Laboratories' H1 Attributable Profit Surges; Revenue Up | MT |
| 08-28 | Joinn Laboratories(China)Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Joinn Laboratories(China)Co.,Ltd.(603127)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Joinn Laboratories(China)Co.,Ltd.(603127)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Joinn Laboratories(China)Co.,Ltd.(603127)
EBIT
Dividend / Share (DPS)
Data source:
Joinn Laboratories(China)Co.,Ltd.(603127)
Cash or Net Debt
- Stock Market
- Stocks
- 603127 Stock
- 6127 Stock
- Consensus Joinn Laboratories(China)Co.,Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
